The world faces major challenges: access to medicine, diffusion of green technology needed to fight climate change, and a balanced Internet governance. While flexibility is essential to solve these major issues, the Anti-Counterfeiting Trade Agreement (ACTA) codifies draconian measures. ACTA’s predecessor, the 1994 WTO TRIPS agreement, still hampers fair trade, even in life saving generic medicines. The EU should have chosen to further balance, in the World Trade Organization, the TRIPS agreement.
It is not too late. ACTA goes beyond US law, the US will not ratify ACTA. The Mexican Senate urged the government not to sign ACTA. India, Brazil and China have turned against ACTA. The EU can and should reject ACTA, and seek a balanced solution in WTO and WIPO.
Otherwise, it is the EU itself that will suffer under ACTA, while its competitors will not. ACTA’s measures are meant to paralyze people. ACTA’s intrusive character harms health and freedom of expression. ACTA will have a chilling effect on innovation, Internet service providers, mass digitization projects, startup companies and diffusion of green technology.
We will give two examples of a global pricing problem that ACTA will not solve but aggravate. We will show ACTA’s measures are draconian and go beyond current EU law. ACTA will hamper essential freedom to act and innovate in the knowledge society.
Read More: The world faces major challenges